VERUProduct Developmentbusinesswire

Laxxon Medical Announces Successful Product Development Milestone with Novel Oral Modified-Release Formulation of Veru’s Enobosarm, Utilizing Laxxon’s SPID®-Technology

Sentiment:Positive (70)

Summary

NEW YORK--(BUSINESS WIRE)--Laxxon - Veru Announcement

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 11, 2025 by businesswire

    Laxxon Medical Announces Successful Product Development Milestone with Novel Oral Modified-Release Formulation of Veru’s Enobosarm, Utilizing Laxxon’s SPID®-Technology | VERU Stock News | Candlesense